Back to search

Article

Plasma biomarker levels and cognitive decline in a heterogenous community-based cohort with multiple comorbidities

2026-06-01

Abstract excerpt

<h4>ABSTRACT</h4> <h4>INTRODUCTION</h4> Knowledge about how Alzheimer’s disease (AD) and AD-related dementia (AD/ADRD) plasma biomarkers relate to global and domain-specific cognitive functioning across diagnostic groups remains limited, particularly in heterogeneous, community-dwelling populations with multiple comorbidities. <h4>METHODS</h4> We evaluated associations between baseline plasma biomarker levels (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfcc51c9-51bf-585d-967c-e178629b8fd4
DOI
10.64898/2026.05.29.26354375
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma biomarker levels and cognitive decline in a heterogenous community-based cohort with multiple comorbiditiesDOI 10.64898/2026.05.29.26354375
The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adultsSemantic proximity
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity
Multi-domain AD risk burden and plasma biomarkers in cognitively unimpaired adultsSemantic proximity
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based studySemantic proximity
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseSemantic proximity
Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseasesSemantic proximity
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s diseaseSemantic proximity
Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity
Select a neighboring publication to make it the new centre.